Thursday, February 02, 2023 10:42:46 AM
Sepsis Diagnostics Market Size to Surpass USD 1582.23 Million by 2030 at 9.80% CAGR – Report by Market Research Future (MRFR)
Sepsis Diagnostics Market Trends and Insights By Technology (Molecular Diagnostics, Biomarkers, Immunoassays and others), Type of Product (Kits, Instruments, Blood Culture Media and others), End Users (Pathology Laboratories, Specialty Clinics, Hospitals, Diagnostic Centers and others), Competitive Market Growth, Size, Share and Forecast to 2030
February 02, 2023 09:00 ET
| Source: Market Research Future
New York, USA, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Sepsis Diagnostics Market Overview
According to a Comprehensive Research Report by Market Research Future (MRFR), “Sepsis Diagnostics Market Information By Technology, Type of Product, End Users And Region - Forecast till 2030", the market is expected to gain a market value of USD 1,582.23 million by 2030 at a CAGR of 9.80% over the forecast period of 2022-2030.
Market Synopsis
Sepsis is a potentially fatal condition resulting from the body's immune system attacking its own tissues in response to an infection. Organs perform badly and inappropriately when the body's infection-fighting mechanisms are activated. As a result of the body's immune system attacking its tissues in response to an infection, sepsis is potentially lethal. Organs perform badly and inappropriately when the body's infection-fighting mechanisms are activated. Sepsis can lead to septic shock. This unexpected drop in blood pressure can seriously harm organs and even result in death. The likelihood of survival is improved by receiving intravenous fluids and antibiotics as soon as feasible. With the creation and introduction of such sophisticated, fast testing, major industry participants would have profitable prospects to improve their market position. Over the forecast period, the rising approval process and the launch of technologically sophisticated diagnostic solutions are anticipated to be the key drivers of market expansion.
Nosocomial infections, sometimes called hospital-acquired infections or HAIs, are a major cause of morbidity and mortality worldwide. The most common hospital-acquired infections are urinary tract infections, bronchitis, and sepsis (HAIs). Due to the rising incidence of sepsis and the growing global geriatric population, sepsis diagnosis is anticipated to have considerable market expansion throughout the predicted period. Increased government support for sepsis-related research initiatives and an increase in the prevalence of infectious diseases are the main drivers fueling the market's expansion.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/2110
https://www.globenewswire.com/news-release/2023/02/02/2600533/0/en/Sepsis-Diagnostics-Market-Size-to-Surpass-USD-1582-23-Million-by-2030-at-9-80-CAGR-Report-by-Market-Research-Future-MRFR.html
Recent CTSO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:14:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:00:30 PM
- CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- CytoSorbents to Report First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 04/26/2024 11:00:00 AM
- STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- CytoSorbents to Report Fiscal 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 10:20:45 PM
- Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients • GlobeNewswire Inc. • 01/17/2024 12:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/08/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:49:02 PM
- CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation • GlobeNewswire Inc. • 12/28/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:35:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:33:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:31:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 02:15:22 PM
- CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering • GlobeNewswire Inc. • 12/13/2023 02:15:00 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM